In short
Covidien and GE Healthcare, technology giants and recognised innovators in patient monitoring and respiratory care devices, today announced a five-year, global collaboration to incorporate Covidien measurement technologies into GE Healthcare patient monitors.
Background
It’s consolidation time again as industrial giants Covidien and GE Healthcare decide they gain more from working together than they could do apart.
A joint press release states that integration of clinical information to an extent made possible by this collaboration, can provide valuable information for physicians, helping guide their decisions and enhance efficiency of care.
Covidien’s Nellcor™ Respiratory Function portfolio, which includes Nellcor pulse oximetry with OxiMax™ Technology, and the BIS™ Brain Monitoring system, are already available on many GE Healthcare patient monitors. This includes the CARESCAPE™ Monitor B850 and CARESCAPE™ Monitor B650, which combine GE Healthcare’s strong cardiac and anesthesiology heritage.
GE Healthcare say the Covidien collaboration reflects its commitment to maintain an open monitoring architecture, bringing together streams of patient data and making it usable for clinicians at the point of care. For instance, the CARESCAPE™ Monitor B850 now provides access to Covidien measurements, bi-directional information flows between the monitor and hospital information systems, such as electronic medical records, and electrocardiogram measurements without requiring a separate monitor.
Company comments
For GE Healthcare
“GE Healthcare is committed to making a broad range of parameter measurements available on our powerful monitoring technology, including GE’s own SpO2 technology,” said Matthias Weber, General Manager, Monitoring Solutions at GE Healthcare. “Leveraging our 100-year history of designing life-critical devices, we are focused on delivering innovative clinical measurement technology. Such advances have the potential to support improved care, quality, and patient safety.”
For Covidien
“The advanced parameter portfolio from Covidien, coupled with GE Healthcare’s patient monitors, supports clinicians in detecting subtle but critical variations in a patient’s status,” says Robert J. White, President of Covidien Respiratory and Monitoring Solutions. “By delivering the full picture of a patient’s physiological status, patient safety and positive outcomes can be advanced.”
Source: Covidien PLC, GE Healthcare, Business Wire
published: May 4, 2012 in: Anaesthesia, Covidien, News, Technology, Thoracic/Respiratory